Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126116193 | 12611619 | 3 | F | 201606 | 20160816 | 20160801 | 20160830 | EXP | US-ACORDA-ACO_126453_2016 | ACORDA | 35.00 | YR | F | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126116193 | 12611619 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Unknown | UNK | U | U | 22250 | TABLET | |||||||
126116193 | 12611619 | 2 | SS | PLEGRIDY | PEGINTERFERON BETA-1A | 1 | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126116193 | 12611619 | 1 | Gait disturbance |
126116193 | 12611619 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126116193 | 12611619 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126116193 | 12611619 | Abdominal discomfort | |
126116193 | 12611619 | Anxiety | |
126116193 | 12611619 | Arthralgia | |
126116193 | 12611619 | Back injury | |
126116193 | 12611619 | Chills | |
126116193 | 12611619 | Dislocation of vertebra | |
126116193 | 12611619 | Dizziness | |
126116193 | 12611619 | Dysstasia | |
126116193 | 12611619 | Eating disorder | |
126116193 | 12611619 | Fatigue | |
126116193 | 12611619 | Fear | |
126116193 | 12611619 | Feeling abnormal | |
126116193 | 12611619 | Feeling hot | |
126116193 | 12611619 | Frustration tolerance decreased | |
126116193 | 12611619 | Gait disturbance | |
126116193 | 12611619 | Headache | |
126116193 | 12611619 | Hyperhidrosis | |
126116193 | 12611619 | Hypokinesia | |
126116193 | 12611619 | Influenza like illness | |
126116193 | 12611619 | Injection site erythema | |
126116193 | 12611619 | Injection site necrosis | |
126116193 | 12611619 | Injection site pain | |
126116193 | 12611619 | Irritability | |
126116193 | 12611619 | Lethargy | |
126116193 | 12611619 | Migraine | |
126116193 | 12611619 | Musculoskeletal pain | |
126116193 | 12611619 | Musculoskeletal stiffness | |
126116193 | 12611619 | Nervousness | |
126116193 | 12611619 | Pain | |
126116193 | 12611619 | Pallor | |
126116193 | 12611619 | Pruritus | |
126116193 | 12611619 | Sleep terror | |
126116193 | 12611619 | Stress | |
126116193 | 12611619 | Syncope | |
126116193 | 12611619 | Systemic lupus erythematosus | |
126116193 | 12611619 | Temperature intolerance | |
126116193 | 12611619 | Tension | |
126116193 | 12611619 | Vomiting | |
126116193 | 12611619 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |